Best Investments/trading ideas for the weekJoin our free webinar on September23,2026.

Let's get started...
Best Investments/trading ideas for the weekJoin our free webinar on September23,2026.

Let's get started...
| Role | Insider | Date | Transaction | Value | Shares |
|---|---|---|---|---|---|
| Director | Ben Yong | Sep 14, 2026 | Sell | $15.68K | 2,000 |
| Chief Business Officer | Saxena Nishant C | Aug 11, 2026 | Buy | $25.04K | 2,600 |
| CEO | Cohen Yuval | Aug 7, 2026 | Sell | $171.4K | 17,000 |
| CFO | Moran Sean F. | Aug 7, 2026 | Sell | $120.97K | 12,000 |
| Director | Jenkins John Kenneth | Jun 10, 2026 | Sell | $37.99K | 4,800 |
| Director | Altmeyer Anne | Jun 10, 2026 | Sell | $19.09K | 2,412 |
| Director | Kung Winston | Jun 10, 2026 | Sell | $16.03K | 2,026 |
| Chief Business Officer | Saxena Nishant C | Jun 3, 2026 | Buy | $68.22K | 9,000 |
| Chief Business Officer | Saxena Nishant C | Jun 2, 2026 | Buy | $33K | 4,500 |
| Chief Medical Officer | Smethurst Dominic | Mar 2, 2026 | Sell | $50.6K | 6,097 |
| Chief Operating Officer | Hodgson Ian | Feb 17, 2026 | Sell | $6.25K | 847 |
| CEO | Cohen Yuval | Feb 13, 2026 | Sell | $107.95K | 13,871 |
| CFO | Moran Sean F. | Feb 13, 2026 | Sell | $36.59K | 4,701 |
| Chief Operating Officer | Hodgson Ian | Feb 3, 2026 | Sell | $19.54K | 2,415 |
| Chief Medical Officer | Smethurst Dominic | Feb 3, 2026 | Sell | $26.57K | 3,285 |
| 10% Owner | Cormorant Asset Management, LP | Dec 11, 2025 | Sell | $344.01K | 30,029 |
| CEO | Cohen Yuval | Oct 27, 2025 | Sell | $153.8K | 8,973 |
| CFO | Moran Sean F. | Oct 24, 2025 | Sell | $220.94K | 12,981 |
| CEO | Cohen Yuval | Oct 24, 2025 | Sell | $317.41K | 18,660 |
| Director | Altmeyer Anne | Oct 20, 2025 | Sell | $21.73K | 1,060 |
| Director | Jenkins John Kenneth | May 30, 2025 | Sell | $20.47K | 2,783 |
| Director | Altmeyer Anne | May 30, 2025 | Sell | $10.1K | 1,392 |
| Chief Medical Officer | Smethurst Dominic | Mar 6, 2025 | Sell | $43.33K | 6,393 |
| CFO | Moran Sean F. | Feb 14, 2025 | Sell | $24.45K | 2,792 |
| CEO | Cohen Yuval | Feb 14, 2025 | Sell | $62.46K | 7,134 |
Open-market purchases and sales reported on SEC form 4 over the last 10years. Awards, option exercises, gifts and other non-market form 4 activity are excluded. Chart markers group a day's filings by direction; the table lists each filing.